美国知识产权许可收益质押融资模式分析——基于Dyax生物医药高科技融资项目的实证研究

Analysis on the U.S. Intellectual Property Licensing Revenue Pledge Loan Model: Based on the Empirical Study on the High-tech Biomedical Plege Loan of Dyax Corp

知识产权质押融资业务是拓宽战略性新兴企业融资渠道的重要途径,但由于其"评估难、处置难、高风险"的特征,在我国进行市场化推广存在较大困难。通过案例研究及数理统计分析,对美国知识产权许可收益质押融资模式进行研究,从模式创新与制度创新两个层面总结其政策成因,以期为发展我国知识产权质押融资业务提供借鉴。

IPR pledge loan business is an important way to broaden the strategic new financing channels for SMEs, but its assessment and disposal is difficult, so the promotion is more difficult in our country. Analysing the U.S. intellectual property licensing revenue pledge loan model through case studies and mathematical statistics, we summarize its policy causes from legal and commercial levels in order to provide a reference for the development of China＇s IPR pledge loan businesses.